1OF2 image
Entry Detail
PDB ID:
1OF2
Keywords:
Title:
Crystal structure of HLA-B*2709 complexed with the vasoactive intestinal peptide type 1 receptor (VIPR) peptide (residues 400-408)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2003-04-04
Release Date:
2004-01-29
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HUMAN LYMPHOCYTE ANTIGEN HLA-B27
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:BETA-2-MICROGLOBULIN
Chain IDs:B
Chain Length:100
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Description:VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR
Chain IDs:C
Chain Length:9
Number of Molecules:1
Biological Source:HOMO SAPIENS
Primary Citation
Dual, Hla-B27 Subtype-Dependent Conformation of a Self-Peptide
J.Exp.Med. 199 271 ? (2004)
PMID: 14734527 DOI: 10.1084/JEM.20031690

Abstact

The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. The subtypes also generate differential T cell repertoires as exemplified by distinct T cell responses against the self-peptide pVIPR (RRKWRRWHL). The crystal structures described here show that pVIPR binds in an unprecedented dual conformation only to HLA-B*2705 molecules. In one binding mode, peptide pArg5 forms a salt bridge to Asp116, connected with drastically different interactions between peptide and heavy chain, contrasting with the second, conventional conformation, which is exclusively found in the case of B*2709. These subtype-dependent differences in pVIPR binding link the emergence of dissimilar T cell repertoires in individuals with HLA-B*2705 or HLA-B*2709 to the buried Asp116/His116 polymorphism and provide novel insights into peptide presentation by major histocompatibility antigens.

Legend

Protein

Chemical

Disease